Stem Cells and Patenting and Related Regulatory Issues: A United States Perspective

1 min

This article, which appears in the Fall 2005 edition of Bio-Science Law Review, relates to the current position in the United States on the patentability of stem cell related intellectual property, the regulation of human embryo cell line research at both the state and federal level, and the relationship, if any, between patentability and regulation.